Literature DB >> 2465771

Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts.

J Goudsmit1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2465771     DOI： 10.1097/00002030-198800001-00006

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  10 in total

1.  Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons.

Authors:  N L Haigwood; P L Nara; E Brooks; G A Van Nest; G Ott; K W Higgins; N Dunlop; C J Scandella; J W Eichberg; K S Steimer
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

2.  Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development.

Authors:  Kathryn E Stephenson; George H Neubauer; Ulf Reimer; Nikolaus Pawlowski; Tobias Knaute; Johannes Zerweck; Bette T Korber; Dan H Barouch
Journal:  J Immunol Methods       Date:  2014-11-15       Impact factor: 2.303

3.  Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates.

Authors:  P Horal; B Svennerholm; S Jeansson; L Rymo; W W Hall; A Vahlne
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Patterns of antibody reactivity to selected human immunodeficiency virus type 1 (HIV-1) gp160 epitopes infected individuals grouped according to CD4+ cell levels.

Authors:  R Q Warren; H Wolf; R A Zajac; R N Boswell; P Kanda; R C Kennedy
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

5.  Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies.

Authors:  J M Ball; K E Rushlow; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

6.  Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.

Authors:  H Ida; A Kurata; K Eguchi; A Kawakami; K Migita; T Fukuda; T Nakamura; Y Kusumoto; J A Berzofsky; S Nagataki
Journal:  J Clin Immunol       Date:  1991-05       Impact factor: 8.317

7.  B epitopes and selection pressures in feline immunodeficiency virus envelope glycoproteins.

Authors:  G Pancino; C Chappey; W Saurin; P Sonigo
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

8.  Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1.

Authors:  R L Willey; M A Martin; K W Peden
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus.

Authors:  Luzia M Mayr; Rebecca L Powell; Johnson N Ngai; William A Takang; Arthur Nádas; Phillipe N Nyambi
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

Review 10.  Identifying epitopes of HIV-1 that induce protective antibodies.

Authors:  Susan Zolla-Pazner
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.